In March, psychiatrist Peter Gleason prepared to board a train to Maryland after giving a speech to physicians at a luncheon meeting on Long Island, N.Y.
According to a report by Alex Berenson in The New York Times on July 22, Gleason was surrounded by a half-dozen federal agents, handcuffed and driven to a nearby police station. At first, Gleason assumed this was part of an elaborate joke, but he soon discovered that the agents were real and his legal troubles were just beginning. To Gleason’s surprise, he was charged with promoting a drug for purposes not approved by the Food and Drug Administration, so-called off-label promotion — a practice repeated many times in countless physicians’ offices every day.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
